[pending] METOPROLOL TARTRATE (METOPROLOL TARTRATE)
Pending LLM rewrite. Source: FDA_DRUG D-0582-2025.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Pending LLM scoring against the rubric.
Plain-English summary
CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
The recalled product
- Product
- METOPROLOL TARTRATE (METOPROLOL TARTRATE)
- Brand
- METOPROLOL TARTRATE
- Manufacturer
- Westminster Pharmaceuticals LLC
- Category
- Drug — Drugs
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Batch # R56240011
- Exp Date: 2/28/26
- Batch # R56240021
- R56240031
- Exp Date: 3/31/26
- Batch # R56240041
- R56240051
- R56240061
- Exp Date: 4/30/26
- Batch # R56240071
- Exp Date: 7/31/26
UPCs (3)
- 0369367355018
- 0369367354103
- 0369367354011
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOPROLOL TARTRATE
- HighMetoprolol Tartrate Tablets Recalled Nationwide for Metal Contamination
FDA (Drugs) · 2024-06-05
- HighMetoprolol Tartrate Tablets Recalled for Foreign Metal in Tablets
FDA (Drugs) · 2022-01-19
- HighMetoprolol Tartrate Tablets Recalled for Metal Wire Contamination
FDA (Drugs) · 2021-09-29
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27